Publikationen in Zusammenarbeit mit Forschern von Charles University in Prague (4)

2014

  1. Final overall survival: Fulvestrant 500 mg vs 250 mg in the randomized confirm trial

    Journal of the National Cancer Institute, Vol. 106, Núm. 1

  2. Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: Investigation in the QUASAR2 study, systematic review, and meta-analysis

    Journal of Clinical Oncology, Vol. 32, Núm. 10, pp. 1031-1039

2013

  1. Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: Application of new methodology

    Breast Cancer Research and Treatment, Vol. 138, Núm. 1, pp. 149-155

2010

  1. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast

    Journal of the National Cancer Institute - Monographs, Vol. 41, pp. 162-177